gp 1-515 has been researched along with rolipram in 1 studies
Studies (gp 1-515) | Trials (gp 1-515) | Recent Studies (post-2010) (gp 1-515) | Studies (rolipram) | Trials (rolipram) | Recent Studies (post-2010) (rolipram) |
---|---|---|---|---|---|
8 | 0 | 0 | 1,604 | 17 | 401 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boyle, D; Eigler, A; Endres, S; Erhardt, S; Firestein, GS; Hartmann, G; Matschke, V | 1 |
1 other study(ies) available for gp 1-515 and rolipram
Article | Year |
---|---|
Suppression of TNF-alpha production in human mononuclear cells by an adenosine kinase inhibitor.
Topics: Adenosine; Adenosine Kinase; Adenosine Monophosphate; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Depression, Chemical; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Humans; Interleukin-10; Leukocytes, Mononuclear; Phosphodiesterase Inhibitors; Ribonucleosides; Rolipram; Second Messenger Systems; Thionucleotides; Tumor Necrosis Factor-alpha | 2000 |